Integer Holdings Co. (NYSE:ITGR) Receives Consensus Rating of “Moderate Buy” from Analysts

Integer Holdings Co. (NYSE:ITGR) has received an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $146.56.

Several analysts recently weighed in on ITGR shares. KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Citigroup boosted their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Finally, Truist Financial boosted their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th.

Institutional Investors Weigh In On Integer

A number of large investors have recently modified their holdings of the business. Vise Technologies Inc. boosted its position in Integer by 8.3% in the fourth quarter. Vise Technologies Inc. now owns 4,702 shares of the medical equipment provider’s stock valued at $623,000 after buying an additional 362 shares during the last quarter. Squarepoint Ops LLC raised its stake in shares of Integer by 25.7% during the 4th quarter. Squarepoint Ops LLC now owns 3,162 shares of the medical equipment provider’s stock worth $419,000 after buying an additional 646 shares during the period. Teza Capital Management LLC raised its stake in shares of Integer by 11.6% during the 4th quarter. Teza Capital Management LLC now owns 2,727 shares of the medical equipment provider’s stock worth $361,000 after buying an additional 284 shares during the period. ProShare Advisors LLC raised its stake in Integer by 44.4% in the 4th quarter. ProShare Advisors LLC now owns 10,051 shares of the medical equipment provider’s stock valued at $1,332,000 after purchasing an additional 3,091 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Integer by 3.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,678 shares of the medical equipment provider’s stock valued at $2,740,000 after purchasing an additional 685 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

ITGR stock opened at $143.40 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The business has a 50-day moving average price of $137.92 and a 200 day moving average price of $132.20. The company has a market capitalization of $4.81 billion, a P/E ratio of 44.26, a PEG ratio of 1.80 and a beta of 1.13. Integer has a 1-year low of $97.49 and a 1-year high of $146.36.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.